{"blog": [], "keywords": [{"value": "Editorials", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Medicare", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Obama, Barack", "name": "persons", "rank": "6", "is_major": "N"}, {"value": "United States", "name": "glocations", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/05/opinion/runaway-drug-prices.html", "document_type": "article", "byline": {"person": [], "original": "By THE EDITORIAL BOARD", "contributor": "", "organization": "THE EDITORIAL BOARD"}, "type_of_material": "Editorial", "multimedia": [{"url": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbWide.jpg", "legacy": {"wide": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/05/05/opinion/05tue1web/05tue1web-articleLarge.jpg", "legacy": {"xlarge": "images/2015/05/05/opinion/05tue1web/05tue1web-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/05/05/opinion/05tue1web/05tue1web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Opinion", "word_count": "659", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The Obama administration and some states are tackling the lack of transparency and the rising costs.", "pub_date": "2015-05-05T00:00:00Z", "news_desk": "Editorial", "headline": {"kicker": "Editorial", "print_headline": "Runaway Drug Prices", "main": "Runaway Drug Prices", "content_kicker": "Editorial"}, "print_page": "22", "snippet": "The Obama administration and some states are tackling the lack of transparency and the rising costs.", "_id": "55486f7738f0d81a8df266c8", "slideshow_credits": null, "abstract": "Editorial welcomes Obama administration's request that Congress allow Medicare officials to negotiate drug prices directly with manufacturers, in effort to bring transparency to process; expresses hope that states will do same, with bills in offing to impose new cost reporting procedures; contends manufacturers should be forced to either justify increasingly higher prices or restrain increases so Americans can buy drugs at affordable costs."}